Skip to Content

News Release

Option Care Health Reports Financial Results for Fourth Quarter and Full Year 2022 and Announces Share Repurchase Authorization

February 23, 2023 at 7:00 AM EST

BANNOCKBURN, Ill., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the fourth quarter and full year ended December 31, 2022.

Fourth Quarter 2022 Financial Highlights

  • Net revenue of $1,027.2 million, up 10.8% compared to $927.2 million in the fourth quarter of 2021
  • Gross profit of $231.1 million, or 22.5% of revenue, up 8.9% compared to $212.2 million, or 22.9% of revenue, in the fourth quarter of 2021
  • Net income of $47.5 million, or $0.26 earnings per share, inclusive of the impact from the sale of certain of the Company's respiratory therapy assets, compared to net income of $75.5 million, or $0.42 earnings per share, inclusive of a one-time benefit from the elimination of the Company's valuation allowance on deferred tax assets in the fourth quarter of 2021
  • Adjusted EBITDA of $94.3 million, or up 8.7% compared to $86.8 million in the fourth quarter of 2021
  • Cash flow from operations of $43.5 million, and cash balances of $294.2 million at the end of the fourth quarter
  • The Company divested and sold certain respiratory therapy assets in December 2022 for expected total proceeds of $18.4 million, which resulted in a $10.3 million pre-tax gain

Full Year 2022 Financial Highlights

  • Net revenue of $3,944.7 million, up 14.7% compared to $3,438.6 million in full year 2021
  • Gross profit of $866.9 million, or 22.0% of revenue, up 11.2% compared to $779.6 million, or 22.7% of revenue, in full year 2021
  • Net income of $150.6 million, or $0.83 basic earnings per share, compared to net income of $139.9 million, or $0.78 basic earnings per share, in full year 2021
  • Adjusted EBITDA of $342.9 million, up 18.3% compared to $289.8 million in full year 2021
  • Cash flow from operations of $267.5 million, up 28.2% compared to $208.6 million in full year 2021

John C. Rademacher, Chief Executive Officer, commented, “The Option Care Health team's commitment to high-quality, cost-effective care produced solid financial results in 2022. The strength and resilience of our technology-enabled national network has enabled our ability to navigate market dynamics, execute on organic growth opportunities and to capitalize on strategic investments. We are proud of the financial results we delivered and look to continue to build on this momentum in 2023 as we focus on providing extraordinary patient care in the post-acute and ambulatory settings.”

Share Repurchase Program

The Company announced today that its Board of Directors authorized the Company to repurchase up to $250 million shares of its common stock. The extent to which the Company repurchases shares, and the timing of such repurchases, will depend upon a variety of factors, including market conditions, regulatory requirements and other corporate considerations, as determined by the Company’s management.

Mike Shapiro, Chief Financial Officer, commented, “We continue to believe that disciplined pursuit of acquisitions continues to represent an attractive strategy to deploy capital in an accretive manner. We believe the authorization to repurchase common stock provides additional flexibility and optionality as we focus on capital deployment.”

Full Year 2023 Financial Guidance

For the full year 2023, Option Care Health expects to deliver the following financial results:

  • Net revenue of $4.15 billion to $4.375 billion
  • Adjusted EBITDA of $370 million to $390 million
  • Cash flow from operations of at least $240 million

Additionally, the Company anticipates an effective tax rate of 27% - 29% and net interest expense of approximately $61.0 million to $65.0 million.

Conference Call

Option Care Health will host a conference call to discuss its financial results later today at 8:30 a.m. EST. The conference call can be accessed via a live audio webcast that will be available online at A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.

About Option Care Health

Option Care Health is the nation’s largest independent provider of home and alternate site infusion services. With over 7,500 team members, including more than 4,500 clinicians, we work compassionately to elevate standards of care for patients with acute and chronic conditions in all 50 states. Through our clinical leadership, expertise and national scale, Option Care Health is reimagining the infusion care experience for patients, customers and teammates. To learn more, please visit our website at

Investor Contacts

Mike Shapiro Bob East, Asher Dewhurst, Jordan Kohnstam
Chief Financial Officer Westwicke
T: (312) 940-2538 T: (413) 213-0500

Forward-Looking Statements - Safe Harbor

This press release may contain “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “believe,” “project,” “estimate,” “expect,” “may,” “should,” “will” and similar references to future periods. Examples of forward-looking statements include, among others, statements we may make regarding future revenues, future earnings, regulatory developments, market developments, new products and growth strategies, integration activities and the effects of any of the foregoing on our future results of operations or financial conditions.

Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: (i) changes in laws and regulations applicable to our business model; (ii) changes in market conditions and receptivity to our services and offerings; (iii) results of litigation; and (iv) the loss of one or more key payers. For a detailed discussion of the risk factors that could affect our actual results, please refer to the risk factors identified in our SEC reports as filed with the SEC.

Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Note Regarding Use of Non-GAAP Financial Measures

In addition to reporting financial information in accordance with generally accepted accounting principles (GAAP), the Company is also reporting Adjusted EBITDA, which is a non-GAAP financial measure. Adjusted EBITDA is not a measurement of financial performance under GAAP and should not be used in isolation or as a substitute or alternative to net income, operating income or any other performance measure derived in accordance with GAAP, or as a substitute or alternative to cash flow from operating activities or a measure of the Company’s liquidity. In addition, the Company's definition of Adjusted EBITDA may not be comparable to similarly titled non-GAAP financial measures reported by other companies. Adjusted EBITDA, as defined by the Company, represents net income before net interest expense, income tax expense, depreciation and amortization, stock-based compensation expense, loss on extinguishment of debt, and restructuring, acquisition, integration and other. As part of restructuring, acquisition, integration and other, the Company may incur significant charges such as the write down of certain long‑lived assets, temporary redundant expenses, professional fees, potential retention and severance costs and potential accelerated payments or termination costs for certain of its contractual obligations. Management believes that Adjusted EBITDA provides useful supplemental information regarding the performance of Option Care Health’s business operations and facilitates comparisons to the Company’s historical operating results. We have not reconciled Adjusted EBITDA guidance to net income as management believes creation of this reconciliation would not be practicable due to the uncertainty regarding, and potential variability of, material reconciling items. For a full reconciliation of Adjusted EBITDA to the most comparable GAAP financial measure, please see below.

Schedule 1

(IN THOUSANDS)(Unaudited)


  December 31,
  2022   2021
Cash and cash equivalents $ 294,186   $ 119,423
Accounts receivable, net   377,542     338,242
Inventories   224,281     183,095
Prepaid expenses and other current assets   98,330     69,496
Total current assets   994,339     710,256
Property and equipment, net   108,321     111,535
Intangible assets, net   22,371     21,433
Referral sources   341,744     344,587
Goodwill   1,533,424     1,477,564
Other noncurrent assets   112,737     125,543
Total noncurrent assets   2,118,597     2,080,662
TOTAL ASSETS $ 3,112,936   $ 2,790,918
Accounts payable $ 378,763   $ 279,246
Other current liabilities   186,588     180,449
Total current liabilities   565,351     459,695
Long-term debt, net of discount, deferred financing costs and current portion   1,058,204     1,059,900
Other noncurrent liabilities   103,278     95,437
Total noncurrent liabilities   1,161,482     1,155,337
Total liabilities   1,726,833     1,615,032
STOCKHOLDERS' EQUITY   1,386,103     1,175,886

Schedule 2



  Three Months Ended
December 31,
  Year Ended
December 31,
    2022       2021       2022       2021  
NET REVENUE $ 1,027,213     $ 927,194     $ 3,944,735     $ 3,438,640  
COST OF REVENUE   796,132       714,997       3,077,817       2,659,034  
GROSS PROFIT   231,081       212,197       866,918       779,606  
Selling, general and administrative expenses   148,351       136,777       566,122       525,707  
Depreciation and amortization expense   14,538       14,648       60,565       63,058  
Total operating expenses   162,889       151,425       626,687       588,765  
OPERATING INCOME   68,192       60,772       240,231       190,841  
OTHER INCOME (EXPENSE):              
Interest expense, net   (14,798 )     (14,286 )     (53,806 )     (67,003 )
Other, net   11,387       481       19,343       (7,344 )
Total other expense   (3,411 )     (13,805 )     (34,463 )     (74,347 )
INCOME BEFORE INCOME TAXES   64,781       46,967       205,768       116,494  
INCOME TAX EXPENSE (BENEFIT)   17,252       (28,500 )     55,212       (23,404 )
NET INCOME $ 47,529     $ 75,467     $ 150,556     $ 139,898  
Earnings per share, basic $ 0.26     $ 0.42     $ 0.83     $ 0.78  
Earnings per share, diluted $ 0.26     $ 0.41     $ 0.83     $ 0.77  
Weighted average common shares outstanding, basic   181,925       179,896       181,105       179,855  
Weighted average common shares outstanding, diluted   183,086       181,205       182,075       181,205  

Schedule 3

(IN THOUSANDS)(Unaudited)


  Year Ended
December 31,
  2022   2021
Net income $ 150,556     $ 139,898  
Adjustments to reconcile net income (loss) to net cash provided by operations:      
Depreciation and amortization expense   65,434       68,804  
Deferred income taxes - net   49,187       (30,372 )
Other non-cash adjustments   32,147       41,609  
Changes in operating assets and liabilities:      
Accounts receivable, net   (36,889 )     (4,273 )
Inventories   (41,010 )     (22,700 )
Accounts payable   98,885       (10,381 )
Other   (50,763 )     25,984  
Net cash provided by operating activities   267,547       208,569  
Acquisition of property and equipment   (35,358 )     (25,632 )
Proceeds from sale of assets   14,670        
Business acquisitions, net of cash acquired   (87,364 )     (85,909 )
Net cash used in investing activities   (108,052 )     (111,541 )
Proceeds from debt         855,136  
Retirement of debt obligations         (910,345 )
Proceeds from warrant exercises   20,916        
Deferred financing costs         (10,339 )
Other financing cash flows   (5,648 )     (11,322 )
Net cash provided by (used in) financing activities   15,268       (76,870 )
Cash and cash equivalents - beginning of the period   119,423       99,265  
CASH AND CASH EQUIVALENTS - END OF PERIOD $ 294,186     $ 119,423  

Schedule 4



  Three Months Ended 
 December 31,
  Year Ended
December 31,
    2022       2021       2022       2021  
Net income $ 47,529     $ 75,467     $ 150,556     $ 139,898  
Interest expense, net   14,798       14,286       53,806       67,003  
Income tax expense (benefit)   17,252       (28,500 )     55,212       (23,404 )
Depreciation and amortization expense   15,711       15,984       65,434       68,804  
EBITDA   95,290       77,237       325,008       252,301  
EBITDA adjustments              
Stock-based incentive compensation   4,202       3,329       16,783       9,575  
Loss on extinguishment of debt         984             13,387  
Gain on sale of assets   (10,325 )           (10,325 )      
Restructuring, acquisition, integration and other   5,105       5,200       11,387       14,543  
Adjusted EBITDA $ 94,272     $ 86,750     $ 342,853     $ 289,806  

Primary Logo

Source: Option Care Health, Inc.